2023
Internal and Environmental Predictors of Physician Practice Use of Screening and Medications for Opioid Use Disorders
Miller-Rosales C, Busch S, Meara E, King A, D’Aunno T, Colla C. Internal and Environmental Predictors of Physician Practice Use of Screening and Medications for Opioid Use Disorders. Medical Care Research And Review 2023, 80: 410-422. PMID: 37036056, PMCID: PMC10949918, DOI: 10.1177/10775587231162681.Peer-Reviewed Original ResearchConceptsOngoing opioid epidemicOpioid use disorderOpioid useUse disordersHealth information technology functionalityAvailability of MOUDPrimary careOpioid epidemicMOUDMultispecialty practicePhysician practicesMedicationsBehavioral cliniciansDemonstrated effectivenessDisordersPractice useScreeningCliniciansCare
2015
Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial
D’Onofrio G, O’Connor P, Pantalon MV, Chawarski MC, Busch SH, Owens PH, Bernstein SL, Fiellin DA. Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial. JAMA 2015, 313: 1636-1644. PMID: 25919527, PMCID: PMC4527523, DOI: 10.1001/jama.2015.3474.Peer-Reviewed Original ResearchConceptsBrief intervention groupOpioid-dependent patientsIllicit opioid useAddiction treatment servicesPercent of patientsBuprenorphine groupEmergency departmentIntervention groupReferral groupOpioid useTreatment servicesBrief interventionOpioid dependenceClinical trialsHIV riskUrban teaching hospital emergency departmentBuprenorphine/naloxone treatmentHuman immunodeficiency virus (HIV) riskTeaching hospital emergency departmentAddiction treatmentBuprenorphine treatment groupUrine samplesBuprenorphine/naloxoneRandomized clinical trialsCommunity-based treatment services